{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:07:18Z","timestamp":1793941638458,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46901-3","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:06:43Z","timestamp":1776305203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics by downregulating the ECM1\/NF-\u03baB\/TGF\u03b2 signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Kaumudi","family":"Pande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi Annapurna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbarasu","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"46901_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"46901_CR2","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program Ovarian Cancer Stats. https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html (2025)."},{"key":"46901_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1055\/s-0044-1801767","volume":"46","author":"S Vemula","year":"2025","unstructured":"Vemula, S. & Dhakshanamoorthy, K. Epidemiology of Cancer Incidence Estimates and Statistics 2000\u20132025: Analysis from National Cancer Registry Programme in India. Indian Journal of Medical and Paediatric Oncology 46, 278\u2013287. https:\/\/doi.org\/10.1055\/s-0044-1801767 (2025).","journal-title":"Indian Journal of Medical and Paediatric Oncology"},{"key":"46901_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3322\/canjclin.49.5.297","volume":"49","author":"EE Partridge","year":"1999","unstructured":"Partridge, E. E. & Barnes, M. N. Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J. Clin. 49, 297\u2013320. https:\/\/doi.org\/10.3322\/canjclin.49.5.297 (1999).","journal-title":"CA Cancer J. Clin."},{"key":"46901_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jbmr.5650090616","volume":"9","author":"E Mathieu","year":"1994","unstructured":"Mathieu, E. et al. Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J. Bone Mineral Res.: Official J. American Soc. Bone Mineral Res. 9, 903\u2013913. https:\/\/doi.org\/10.1002\/jbmr.5650090616 (1994).","journal-title":"J. Bone Mineral Res.: Official J. American Soc. Bone Mineral Res."},{"key":"46901_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.889159","volume":"12","author":"S Long","year":"2022","unstructured":"Long, S. et al. extracellular matrix protein 1 regulates colorectal cancer cell proliferative, migratory, invasive and epithelial-mesenchymal transition activities through the PI3K\/AKT\/GSK3\u03b2\/Snail signaling axis. Front. Oncol. 12, 889159. https:\/\/doi.org\/10.3389\/fonc.2022.889159 (2022).","journal-title":"Front. Oncol."},{"key":"46901_CR7","doi-asserted-by":"publisher","first-page":"25520","DOI":"10.18632\/oncotarget.4550","volume":"6","author":"H Bai","year":"2015","unstructured":"Bai, H. et al. The PI3K\/AKT\/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines. Oncotarget 6, 25520\u201325532. https:\/\/doi.org\/10.18632\/oncotarget.4550 (2015).","journal-title":"Oncotarget"},{"key":"46901_CR8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/ijms24021224","volume":"24","author":"D De Rasmo","year":"2023","unstructured":"De Rasmo, D. et al. Ovarian cancer: a landscape of mitochondria with emphasis on mitochondrial dynamics. Int. J. Mol. Sci. 24, 1224. https:\/\/doi.org\/10.3390\/ijms24021224 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"46901_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167803","volume":"1871","author":"JP Moura","year":"2025","unstructured":"Moura, J. P., Oliveira, P. J. & Urbano, A. M. Mitochondria: An overview of their origin, genome, architecture, and dynamics. Biochimica et Biophysica Acta (BBA) \u2013 Mol. Basis Dis. 1871, 167803. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167803 (2025).","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Mol. Basis Dis."},{"key":"46901_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003453","volume":"23","author":"W Iwata","year":"2025","unstructured":"Iwata, W. et al. Targeting mitochondrial structure and dynamics for therapeutic intervention in cancer. PLoS Biol. 23, e3003453. https:\/\/doi.org\/10.1371\/journal.pbio.3003453 (2025).","journal-title":"PLoS Biol."},{"key":"46901_CR11","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm3013","volume":"11","author":"B Westermann","year":"2010","unstructured":"Westermann, B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11, 872\u2013884. https:\/\/doi.org\/10.1038\/nrm3013 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"46901_CR12","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.7150\/thno.74305","volume":"12","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications. Theranostics. 12, 6548\u20136575. https:\/\/doi.org\/10.7150\/thno.74305 (2022).","journal-title":"Theranostics."},{"key":"46901_CR13","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00216-025-05824-0","volume":"417","author":"C Mata","year":"2025","unstructured":"Mata, C. et al. Isolation of bovine milk-derived extracellular vesicles via a capillary-channeled polymer (C-CP) fiber stationary phase. Anal. Bioanal. Chem. 417, 2345\u20132359. https:\/\/doi.org\/10.1007\/s00216-025-05824-0 (2025).","journal-title":"Anal. Bioanal. Chem."},{"key":"46901_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00253-022-12342-x","volume":"107","author":"WJ Xu","year":"2023","unstructured":"Xu, W. J. et al. Progress in fed-batch culture for recombinant protein production in CHO cells. Appl. Microbiol. Biotechnol. 107, 1063\u20131075. https:\/\/doi.org\/10.1007\/s00253-022-12342-x (2023).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"46901_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201700499","volume":"13","author":"S Pereira","year":"2018","unstructured":"Pereira, S., Kildegaard, H. F. & Andersen, M. R. Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients. Biotechnol. J. 13, e1700499. https:\/\/doi.org\/10.1002\/biot.201700499 (2018).","journal-title":"Biotechnol. J."},{"key":"46901_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/CT8966901287","volume":"69","author":"AG Perkin","year":"1896","unstructured":"Perkin, A. G. & Hummel, J. J. LXXVI-The colouring principle contained in the bark of Myrica nagi Part I. J. Chem. Soc. Trans. 69, 1287\u20131294. https:\/\/doi.org\/10.1039\/CT8966901287 (1896).","journal-title":"J. Chem. Soc. Trans."},{"key":"46901_CR17","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.3892\/ol.2017.6031","volume":"13","author":"AW Zheng","year":"2017","unstructured":"Zheng, A. W. et al. Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells. Oncol. Lett. 13, 4974\u20134978. https:\/\/doi.org\/10.3892\/ol.2017.6031 (2017).","journal-title":"Oncol. Lett."},{"key":"46901_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0306-3623(96)00421-1","volume":"29","author":"KC Ong","year":"1997","unstructured":"Ong, K. C. & Khoo, H. E. Biological effects of myricetin. Gen. Pharmacol. 29, 121\u2013126. https:\/\/doi.org\/10.1016\/s0306-3623(96)00421-1 (1997).","journal-title":"Gen. Pharmacol."},{"key":"46901_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biochi.2017.08.007","volume":"142","author":"H Amani","year":"2017","unstructured":"Amani, H. et al. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants. Biochimie 142, 63\u201379. https:\/\/doi.org\/10.1016\/j.biochi.2017.08.007 (2017).","journal-title":"Biochimie"},{"key":"46901_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111017","volume":"134","author":"X Song","year":"2021","unstructured":"Song, X. et al. Myricetin: A review of the most recent research. Biomed. Pharmacother. 134, 111017. https:\/\/doi.org\/10.1016\/j.biopha.2020.111017 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"46901_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1055\/a-1224-3625","volume":"70","author":"G Gupta","year":"2020","unstructured":"Gupta, G. et al. Current pharmacological trends on myricetin. Drug Res. 70, 448\u2013454. https:\/\/doi.org\/10.1055\/a-1224-3625 (2020).","journal-title":"Drug Res."},{"key":"46901_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4196\/kjpp.2023.27.1.31","volume":"27","author":"SY Lee","year":"2023","unstructured":"Lee, S. Y. et al. Characterization of a conjugated polysuccinimide-carboplatin compound. Korean J. Physiol. Pharmacol. 27, 31\u201338. https:\/\/doi.org\/10.4196\/kjpp.2023.27.1.31 (2023).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"46901_CR23","doi-asserted-by":"publisher","DOI":"10.1590\/acb401725","volume":"40","author":"\u0130 \u00d6zdemir","year":"2025","unstructured":"\u00d6zdemir, \u0130, Akta\u015f, A. \u015e & Tuncer, M. C. Investigation of the effect of thymoquinone and doxorubicin on the EGFR\/FOXP3 signaling pathway in OVCAR3 human ovarian adenocarcinoma cells. Acta Cir. Bras. 40, e401725. https:\/\/doi.org\/10.1590\/acb401725 (2025).","journal-title":"Acta Cir. Bras."},{"key":"46901_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12128","volume":"10","author":"RE Veerman","year":"2021","unstructured":"Veerman, R. E. et al. Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin. J. Extracell. Vesicles 10, e12128. https:\/\/doi.org\/10.1002\/jev2.12128 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"46901_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10529-023-03353-3","volume":"45","author":"E Skrika-Alexopoulos","year":"2023","unstructured":"Skrika-Alexopoulos, E. & Smales, M. C. Isolation and characterisation of exosomes from Chinese hamster ovary (CHO) cells. Biotech. Lett. 45, 425\u2013437. https:\/\/doi.org\/10.1007\/s10529-023-03353-3 (2023).","journal-title":"Biotech. Lett."},{"key":"46901_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-018-1157-7","volume":"8","author":"N Eswaran","year":"2018","unstructured":"Eswaran, N. et al. Simple isolation and characterization of seminal plasma extracellular vesicle and its total RNA in an academic lab. 3 Biotech 8, 139. https:\/\/doi.org\/10.1007\/s13205-018-1157-7 (2018).","journal-title":"3 Biotech"},{"key":"46901_CR27","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.7150\/thno.108296","volume":"15","author":"Q Zhu","year":"2025","unstructured":"Zhu, Q. et al. Bioinspired exosome-SiO2 nanohybrid therapeutic for rheumatoid arthritis treatment. Theranostics 15, 6553\u20136571. https:\/\/doi.org\/10.7150\/thno.108296 (2025).","journal-title":"Theranostics"},{"key":"46901_CR28","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.2147\/IJN.S510352","volume":"20","author":"Z Sun","year":"2025","unstructured":"Sun, Z. et al. Aloe vera gel and rind-derived nanoparticles mitigate skin photoaging via activation of Nrf2\/ARE pathway. Int. J. Nanomed. 20, 4051\u20134067. https:\/\/doi.org\/10.2147\/IJN.S510352 (2025).","journal-title":"Int. J. Nanomed."},{"key":"46901_CR29","unstructured":"Chemical Structure Drawing Software ACD\/ChemSketch. Available online: https:\/\/www.acdlabs.com\/products\/draw_nom\/draw\/chemsketch"},{"key":"46901_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03689-y","volume":"25","author":"FA Attar","year":"2025","unstructured":"Attar, F. A. et al. Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: In vitro and in vivo study. Cancer Cell Int. 25, 72. https:\/\/doi.org\/10.1186\/s12935-025-03689-y (2025).","journal-title":"Cancer Cell Int."},{"key":"46901_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.34172\/apb.2023.072","volume":"13","author":"MS Gholami Farashah","year":"2023","unstructured":"Gholami Farashah, M. S. et al. 17\u03b2-Estradiol-Loaded exosomes for targeted drug delivery in osteoporosis: a comparative study of two loading methods. Adv. Pharma. Bull. 13, 736\u2013746. https:\/\/doi.org\/10.34172\/apb.2023.072 (2023).","journal-title":"Adv. Pharma. Bull."},{"key":"46901_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2461956","volume":"11","author":"KK Sarwareddy","year":"2025","unstructured":"Sarwareddy, K. K. et al. Harnessing tomato-derived small extracellular vesicles as drug delivery system for cancer therapy. Future. Sci. OA. 11, 2461956. https:\/\/doi.org\/10.1080\/20565623.2025.2461956 (2025).","journal-title":"Future. Sci. OA."},{"key":"46901_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11095-023-03648-0","volume":"41","author":"P Dehghani","year":"2024","unstructured":"Dehghani, P. et al. Keratinocyte exosomes for topical delivery of Tofacitinib in treatment of Psoriasis: An in vitro\/in vivo study in animal model of Psoriasis. Pharm. Res. 41, 263\u2013279. https:\/\/doi.org\/10.1007\/s11095-023-03648-0 (2024).","journal-title":"Pharm. Res."},{"key":"46901_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fochx.2022.100431","volume":"15","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y. et al. Delivery of curcumin by shellac encapsulation: Stability, bioaccessibility, freeze-dried redispersibility, and solubilization. Food. Chem. X. 15, 100431. https:\/\/doi.org\/10.1016\/j.fochx.2022.100431 (2022).","journal-title":"Food. Chem. X."},{"key":"46901_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biochi.2013.11.010","volume":"99","author":"M Mansouri","year":"2014","unstructured":"Mansouri, M. et al. The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells. Biochimie 99, 71\u201376. https:\/\/doi.org\/10.1016\/j.biochi.2013.11.010 (2014).","journal-title":"Biochimie"},{"key":"46901_CR36","doi-asserted-by":"publisher","unstructured":"Arunachalam, K., Sreeja, P.S. (2025). MTT Assay Protocol. In: Advanced Cell and Molecular Techniques. Springer Protocols Handbooks. Humana, New York, NY. 271\u2013276. https:\/\/doi.org\/10.1007\/978-1-0716-4518-5_45","DOI":"10.1007\/978-1-0716-4518-5_45"},{"key":"46901_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jfb13040158","volume":"13","author":"VM Kumbar","year":"2022","unstructured":"Kumbar, V. M. et al. Curcumin-encapsulated nanomicelles improve cellular uptake and cytotoxicity in Cisplatin-resistant human oral cancer cells. J. Funct. Biomater. 13, 158. https:\/\/doi.org\/10.3390\/jfb13040158 (2022).","journal-title":"J. Funct. Biomater."},{"key":"46901_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12155","volume":"24","author":"W Jin","year":"2021","unstructured":"Jin, W. & Ye, L. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression. Mol. Med. Rep. 24, 516. https:\/\/doi.org\/10.3892\/mmr.2021.12155 (2021).","journal-title":"Mol. Med. Rep."},{"key":"46901_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1028-z","volume":"38","author":"JC Chang","year":"2019","unstructured":"Chang, J. C. et al. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer. J. Exp. Clin. Cancer Res. 38, 30. https:\/\/doi.org\/10.1186\/s13046-019-1028-z (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"46901_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02420-x","volume":"21","author":"W Hu","year":"2021","unstructured":"Hu, W. et al. FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis. Cancer. Cell. Int. 21, 709. https:\/\/doi.org\/10.1186\/s12935-021-02420-x (2021).","journal-title":"Cancer. Cell. Int."},{"key":"46901_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/toxres\/tfaa029","volume":"9","author":"T Saranya","year":"2020","unstructured":"Saranya, T. et al. Enhanced apoptogenesis and oncogene regulatory mechanism of troxerutin in triple negative breast cancer cells. Toxicol. Res. 9, 230\u2013238. https:\/\/doi.org\/10.1093\/toxres\/tfaa029 (2020).","journal-title":"Toxicol. Res."},{"key":"46901_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12416","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. MISEV2023: An updated guide to EV research and applications. J. Extracell. Vesicles. 13, e12416. https:\/\/doi.org\/10.1002\/jev2.12416 (2024).","journal-title":"J. Extracell. Vesicles."},{"key":"46901_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.20517\/evcna.2024.21","volume":"5","author":"E Amabebe","year":"2024","unstructured":"Amabebe, E. et al. Cargo exchange between human and bacterial extracellular vesicles in gestational tissues: a new paradigm in communication and immune development. Extracellular Vesicles Circulating Nucleic Acids 5, 297\u2013328. https:\/\/doi.org\/10.20517\/evcna.2024.21 (2024).","journal-title":"Extracellular Vesicles Circulating Nucleic Acids"},{"key":"46901_CR44","doi-asserted-by":"publisher","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","volume":"8","author":"L Huang","year":"2023","unstructured":"Huang, L. et al. Research advances of engineered exosomes as drug delivery carrier. ACS Omega 8, 43374\u201343387. https:\/\/doi.org\/10.1021\/acsomega.3c04479 (2023).","journal-title":"ACS Omega"},{"key":"46901_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1049\/iet-nbt.2018.5431","volume":"14","author":"H Guo","year":"2020","unstructured":"Guo, H. et al. Method for enhancing bioavailability of myricetin based on self-assembly of casein-myricetin nanomicelles. IET Nanobiotechnol. 14, 239\u2013244. https:\/\/doi.org\/10.1049\/iet-nbt.2018.5431 (2020).","journal-title":"IET Nanobiotechnol."},{"key":"46901_CR46","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/2837\/1\/012046","volume":"2837","author":"F Hinaz","year":"2024","unstructured":"Hinaz, F., Venkatesan, L. S. & Duraisamy, R. Myricetin-capped biosynthesis of silver-selenium nanoparticles and its anticandidal activities. J. Phys. Conf. Ser. 2837, 012046. https:\/\/doi.org\/10.1088\/1742-6596\/2837\/1\/012046 (2024).","journal-title":"J. Phys. Conf. Ser."},{"key":"46901_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02215-4","volume":"24","author":"J Li","year":"2025","unstructured":"Li, J., Wang, J. & Chen, Z. Emerging role of exosomes in cancer therapy: Progress and challenges. Mol. Cancer. 24, 13. https:\/\/doi.org\/10.1186\/s12943-024-02215-4 (2025).","journal-title":"Mol. Cancer."},{"key":"46901_CR48","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3892\/mmr.2016.4763","volume":"13","author":"Y Xu","year":"2016","unstructured":"Xu, Y. et al. Myricetin induces apoptosis via endoplasmic reticulum stress and DNA double-strand breaks in human ovarian cancer cells. Mol. Med. Rep. 13, 2094\u20132100. https:\/\/doi.org\/10.3892\/mmr.2016.4763 (2016).","journal-title":"Mol. Med. Rep."},{"key":"46901_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biochi.2019.04.023","volume":"162","author":"P Roy","year":"2019","unstructured":"Roy, P. et al. Flavonoid loaded nanoparticles as an effective measure to combat oxidative stress in Ribonuclease A. Biochimie 162, 185\u2013197. https:\/\/doi.org\/10.1016\/j.biochi.2019.04.023 (2019).","journal-title":"Biochimie"},{"key":"46901_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2020.100261","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu, S. et al. Exosome engineering: Current progress in cargo loading and targeted delivery. NanoImpact 20, 100261. https:\/\/doi.org\/10.1016\/j.impact.2020.100261 (2020).","journal-title":"NanoImpact"},{"key":"46901_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep25486","volume":"6","author":"R Navakanitworakul","year":"2016","unstructured":"Navakanitworakul, R. et al. Characterization and small RNA content of extracellular vesicles in follicular fluid of developing bovine antral follicles. Sci. Rep. 6, 25486. https:\/\/doi.org\/10.1038\/srep25486 (2016).","journal-title":"Sci. Rep."},{"key":"46901_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jprot.2012.12.029","volume":"80","author":"B Liang","year":"2013","unstructured":"Liang, B. et al. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J. Proteomics. 80, 171\u2013182. https:\/\/doi.org\/10.1016\/j.jprot.2012.12.029 (2013).","journal-title":"J. Proteomics."},{"key":"46901_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202100646","volume":"17","author":"LE Dyball","year":"2022","unstructured":"Dyball, L. E. & Smales, C. M. Exosomes: Biogenesis, targeting, characterization and their potential as \u201cPlug & Play\u201d vaccine platforms. Biotechnol. J. 17, e2100646. https:\/\/doi.org\/10.1002\/biot.202100646 (2022).","journal-title":"Biotechnol. J."},{"key":"46901_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.vesic.2024.100064","volume":"5","author":"J Junxin Mai","year":"2025","unstructured":"Junxin Mai, J. et al. Packaging of humanized anti-HER2 monoclonal antibody into small extracellular vesicles. Extracellular Vesicle. 5, 100064. https:\/\/doi.org\/10.1016\/j.vesic.2024.100064 (2025).","journal-title":"Extracellular Vesicle."},{"key":"46901_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2022.01.002","volume":"57","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression. Dev. Cell. 57, 329-343.e7. https:\/\/doi.org\/10.1016\/j.devcel.2022.01.002 (2022).","journal-title":"Dev. Cell."},{"key":"46901_CR56","unstructured":"Myricetin Structure. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Myricetin."},{"key":"46901_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11084-w","volume":"15","author":"H Li","year":"2025","unstructured":"Li, H. et al. Predicting flavonoid physicochemical properties using topological indices and regression modeling. Sci. Rep. 15, 27540. https:\/\/doi.org\/10.1038\/s41598-025-11084-w (2025).","journal-title":"Sci. Rep."},{"key":"46901_CR58","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.31032\/IJBPAS\/2025\/14.3.8788","volume":"4","author":"M Narkhede","year":"2025","unstructured":"Narkhede, M. et al. A review on Myricetin and its pharmacological activities. Int. J. Biol., Pharmacy Allied Sci.. 4, 1489\u20131513. https:\/\/doi.org\/10.31032\/IJBPAS\/2025\/14.3.8788 (2025).","journal-title":"Int. J. Biol., Pharmacy Allied Sci.."},{"key":"46901_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119665","volume":"24","author":"AH Rahmani","year":"2023","unstructured":"Rahmani, A. H. et al. Myricetin: A significant emphasis on its anticancer potential via the modulation of inflammation and signal transduction pathways. Int. J. Mol. Sci. 24, 9665. https:\/\/doi.org\/10.3390\/ijms24119665 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"46901_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2011.05.002","volume":"308","author":"PA Phillips","year":"2011","unstructured":"Phillips, P. A. et al. Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett. 308, 181\u2013188. https:\/\/doi.org\/10.1016\/j.canlet.2011.05.002 (2011).","journal-title":"Cancer Lett."},{"key":"46901_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-020-02207-3","volume":"10","author":"N Afroze","year":"2020","unstructured":"Afroze, N. et al. A review on myricetin as a potential therapeutic candidate for cancer prevention. 3 Biotech 10, 211. https:\/\/doi.org\/10.1007\/s13205-020-02207-3 (2020).","journal-title":"3 Biotech"},{"key":"46901_CR62","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.biopha.2017.11.018","volume":"97","author":"MJ Zhang","year":"2018","unstructured":"Zhang, M. J. et al. Chemopreventive effect of Myricetin, a natural occurring compound, on colonic chronic inflammation and inflammation-driven tumorigenesis in mice. Biomed. Pharmacother. 97, 1131\u20131137. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.018 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"46901_CR63","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41374-020-0415-6","volume":"100","author":"SS Steinhaeuser","year":"2020","unstructured":"Steinhaeuser, S. S. et al. ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion. Lab. Invest. 100, 928\u2013944. https:\/\/doi.org\/10.1038\/s41374-020-0415-6 (2020).","journal-title":"Lab. Invest."},{"key":"46901_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9020039","volume":"9","author":"VC Alur","year":"2019","unstructured":"Alur, V. C. et al. mining featured biomarkers linked with epithelial ovarian CancerBased on bioinformatics. Diagnostics 9, 39. https:\/\/doi.org\/10.3390\/diagnostics9020039 (2019).","journal-title":"Diagnostics"},{"key":"46901_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4149\/neo_2012_053","volume":"59","author":"GP Xiong","year":"2012","unstructured":"Xiong, G. P. et al. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell. Neoplasma 59, 409\u2013415. https:\/\/doi.org\/10.4149\/neo_2012_053 (2012).","journal-title":"Neoplasma"},{"key":"46901_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1288883","volume":"14","author":"HW Yang","year":"2023","unstructured":"Yang, H. W. et al. Myricetin suppresses TGF-\u03b2-induced epithelial-to-mesenchymal transition in ovarian cancer. Front. Pharmacol. 14, 1288883. https:\/\/doi.org\/10.3389\/fphar.2023.1288883 (2023).","journal-title":"Front. Pharmacol."},{"key":"46901_CR67","doi-asserted-by":"publisher","first-page":"G275","DOI":"10.1152\/ajpgi.00344.2009","volume":"298","author":"JY Chow","year":"2010","unstructured":"Chow, J. Y. et al. TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells. Gastrointestinal Liver Physiol. 298, G275\u2013G282. https:\/\/doi.org\/10.1152\/ajpgi.00344.2009 (2010).","journal-title":"Gastrointestinal Liver Physiol."},{"key":"46901_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115716","volume":"42","author":"Y Cui","year":"2023","unstructured":"Cui, Y. et al. T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity. Cell Rep. 42, 112797. https:\/\/doi.org\/10.1016\/j.celrep.2025.115716 (2023).","journal-title":"Cell Rep."},{"key":"46901_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06965-4","volume":"20","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi, H. et al. Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer. BMC Cancer 20, 467. https:\/\/doi.org\/10.1186\/s12885-020-06965-4 (2020).","journal-title":"BMC Cancer"},{"key":"46901_CR70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","volume":"24","author":"P Romani","year":"2022","unstructured":"Romani, P. et al. Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. Nat. Cell Biol. 24, 168\u2013180. https:\/\/doi.org\/10.1038\/s41556-022-00843-w (2022).","journal-title":"Nat. Cell Biol."},{"key":"46901_CR71","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1021\/acschemneuro.1c00591","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao, X. et al. Myricetin restores A\u03b2-induced mitochondrial impairments in N2a-SW cells. ACS. Chem. Neurosci. 13, 454\u2013463. https:\/\/doi.org\/10.1021\/acschemneuro.1c00591 (2022).","journal-title":"ACS. Chem. Neurosci."},{"key":"46901_CR72","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2012.494","volume":"32","author":"J Zhao","year":"2013","unstructured":"Zhao, J. et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32, 4814\u20134824. https:\/\/doi.org\/10.1038\/onc.2012.494 (2013).","journal-title":"Oncogene"},{"key":"46901_CR73","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/cas.16064","volume":"115","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1\/2 activation. Cancer Sci. 115, 1536\u20131550. https:\/\/doi.org\/10.1111\/cas.16064 (2024).","journal-title":"Cancer Sci."},{"key":"46901_CR74","doi-asserted-by":"publisher","first-page":"24259","DOI":"10.1073\/pnas.1913919116","volume":"116","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Mutant p53 antagonizes p63\/p73-mediated tumor suppression via Notch1. Proc. Natl. Acad. Sci. U. S. A. 116, 24259\u201324267. https:\/\/doi.org\/10.1073\/pnas.1913919116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"46901_CR75","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.143.2.547","volume":"143","author":"D Ili\u0107","year":"1998","unstructured":"Ili\u0107, D. et al. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143, 547\u2013560. https:\/\/doi.org\/10.1083\/jcb.143.2.547 (1998).","journal-title":"J. Cell Biol."},{"key":"46901_CR76","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1096\/fj.201901747RR","volume":"34","author":"YY Kim","year":"2020","unstructured":"Kim, Y. Y. et al. p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence. FASEB J. 34, 2451\u20132464. https:\/\/doi.org\/10.1096\/fj.201901747RR (2020).","journal-title":"FASEB J."},{"key":"46901_CR77","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1074\/jbc.275.10.7337","volume":"275","author":"M Schuler","year":"2000","unstructured":"Schuler, M. et al. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 275, 7337\u20137342. https:\/\/doi.org\/10.1074\/jbc.275.10.7337 (2000).","journal-title":"J. Biol. Chem."},{"key":"46901_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-014-0071-2","volume":"14","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. Cancer Cell Int. 14, 71. https:\/\/doi.org\/10.1186\/s12935-014-0071-2 (2014).","journal-title":"Cancer Cell Int."},{"key":"46901_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.903394","volume":"12","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Myricetin suppresses ovarian cancer in vitro by activating the p38\/Sapla signaling pathway and suppressing intracellular oxidative stress. Front. Oncol. 12, 903394. https:\/\/doi.org\/10.3389\/fonc.2022.903394 (2022).","journal-title":"Front. Oncol."},{"key":"46901_CR80","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3892\/ijo.2015.3133","volume":"47","author":"H Huang","year":"2015","unstructured":"Huang, H. et al. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway. Int. J. Oncol. 47, 1494\u20131502. https:\/\/doi.org\/10.3892\/ijo.2015.3133 (2015).","journal-title":"Int. J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46901-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46901-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46901-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:34:07Z","timestamp":1780871647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46901-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46901"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46901-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17569"}}